Microsoft Word 10.0.6764;






         =============================================================

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10QSB

 -------- ----------------------------------------------------------------------
 [X]      Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
          Exchange Act of 1934
          FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 2005
 -------- ---------------------------------------------------------------------
          OR
 -------- ---------------------------------------------------------------------
 [ ]      Transition Report Pursuant to Section 13 or 15(d) of the
          Securities Exchange Act of 1934
 -------- ---------------------------------------------------------------------
          For the transition period from to
 -------- ---------------------------------------------------------------------

                         COMMISSION FILE NUMBER: 0-30351

                                True Health, Inc.
             (Exact name of registrant as specified in its charter)
<TABLE>
           -------------------------------------------------- -------------------------------------------
<S>        <C>                                                <C>
           Utah                                               75-2263732
           -------------------------------------------------- -------------------------------------------
           (State of other jurisdiction                       (IRS Employer Identification
           of incorporation or organization)                  Number)
           -------------------------------------------------- -------------------------------------------
</TABLE>
                          Kelsey House, 77 High Street
                                 Beckenham, Kent
                                   UK BR3 1AN
                    (Address of principal executive offices)

                             +(44) (0) 208 658 9575
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
                           Yes [ x ]        No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of  October 31, 2005:      310,686

          =============================================================



<PAGE>



                                TRUE HEALTH, INC.
                           CONSOLIDATED BALANCE SHEET
                                October 31, 2005
                                   (unaudited)

<TABLE>
ASSETS

Current Assets
<S>                                                                                          <C>
  Cash                                                                                         $    1,002
  Accounts receivable, net of the allowance
         for doubtful accounts of $32,099                                                         672,132
  Inventory                                                                                       111,717
  Other                                                                                            44,041
                                                                                              -----------

         Total Current Assets                                                                     828,892
                                                                                              -----------

Fixed assets, net of accumulated depreciation of $369,579                                         225,625
                                                                                              -----------

TOTAL ASSETS                                                                                 $  1,054,517
                                                                                              ===========


LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
  Note payable to factor                                                                      $   401,061
  Current portion of notes payable                                                                 87,946
  Accounts payable                                                                                136,685
  Accrued expenses                                                                                313,246
  Accounts payable to stockholder                                                                 265,769
                                                                                              -----------

         Total Current Liabilities                                                              1,204,707
                                                                                              -----------

Long-term portion of notes payable                                                                 58,862
                                                                                              -----------

         Total Liabilities                                                                      1,263,569
                                                                                              -----------

Stockholders' Deficit
  Convertible preferred stock, $0.01 par value;
  5,000,000 shares authorized; 4,187,977 shares issued
  and outstanding                                                                                   4,188
  Common stock, $.01 par value; 100,000,000 shares
  authorized; 310,686 shares issued and outstanding                                                 3,107
  Additional paid in capital                                                                    2,233,711
  Accumulated deficit                                                                          (2,424,920)
  Accumulated other comprehensive loss                                                            (25,138)
                                                                                              -----------

  Total Stockholders' Deficit                                                                    (209,052)
                                                                                              -----------

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                                              $      1,054,517
                                                                                              ===========
</TABLE>

<PAGE>


                                TRUE HEALTH, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
              Three and Nine Months Ended October 31, 2005 and 2004
                                   (unaudited)



<TABLE>

                                                     Three Months Ended                    Nine Months Ended
                                                   2005              2004             2005             2004
                                                  ----------        ----------        ----------      ----------
<S>                                               <C>               <C>               <C>            <C>
Revenue
- Equipment rentals and sales                     $  653,366        $  452,451        $1,706,387      $1,459,228
- Recruitment services
     and placement fees                              513,515           872,489         1,578,706         3,119,230
- Other                                                7,376             9,447            26,379            30,210
                                                  ----------        ----------        ----------      ----------

Total Revenues                                     1,174,257        1,334,387         3,311,472         4,608,668
Cost of sales                                        650,975           881,741         1,833,626         2,976,484
                                                  ----------        ----------        ----------      ----------

Gross margin                                         523,281           452,646         1,477,845         1,632,184
                                                  ----------        ----------        ----------      ----------

General and administrative
- Non-cash professional fees                               -                 -                 -         600,000
- Other                                              440,160           546,522         1,410,527         1,951,862
Depreciation                                          31,445            29,525            83,354            90,763
                                                  ----------        ----------        ----------      ----------

  Total operating expenses 471,605                   576,047         1,495,881         2,642,625
                                                  ----------        ----------        ----------      ----------

Net Operating Profit/(loss)                           51,677          (123,401)          (18,035)     (1,010,441)

Interest income                                          390                318               762               318
Interest expense                                     (11,572)          (10,753)          (37,539)          (34,916)
                                                  ----------        ----------        ----------      ----------

Net income/(loss) before taxes                        40,494          (133,836)          (54,813)     (1,045,040)

Income tax expense                                         -                 -                 -                 -
                                                  ----------        ----------        ----------      ----------

Net Income/(Loss)                                 $   40,494         (133,836)        $ (54,813)      $(1,045,040)
                                                  ==========        ==========        ==========      ==========

Income (loss) per share:
     Basic                                       $    0.13        $    (0.00)        $    (0.12) $   (0.02)
     Diluted                                     $    0.00        $    (0.00)        $    (0.12) $   (0.02)

Weighted average shares
     outstanding                                    310,698        51,558,179           468,589        50,974,236

</TABLE>



                                TRUE HEALTH, INC.
                      STATEMENTS OF CONSOLIDATED CASH FLOW
                   Nine Months Ended October 31, 2005 and 2004
                                   (unaudited)
<TABLE>
                                                                                   2005                  2004
                                                                                  ----------             ---------
<S>                                                                              <C>                     <C>
Cash Flows From Operating Activities
  Net profit/(loss)                                                                $ (54,813)         $(1,045,040)
  Adjustments to reconcile net loss to net cash
    used in operating activities:
    Depreciation                                                                       91,479              99,314
    Stock issued for services                                                              -               600,000
    Imputed interest on shareholder notes payable                                     16,116                 7,203
    Changes in:
         Accounts receivable                                                        (202,585)               19,882
         Inventory                                                                    25,167              (101,999)
         Other current assets                                                         (5,669)                5,162
         Accounts payable                                                             33,023                12,294
         Accrued expenses                                                            (24,659)              115,090
                                                                                   ---------             ---------

  Net Cash Used in Operating Activities                                             (121,941)             (288,086)
                                                                                   ---------             ---------
Cash Flows Used in Investing Activities
  Purchase of equipment                                                             (114,075)             (104,284)
                                                                                   ---------             ---------
Cash Flows From Financing Activities
  Proceeds from exercise of warrants for stock                                             -               475,000
  Net change in note payable to factor                                                98,147               (82,544)
  Net change in note payable to bank loan                                             (8,034)             (145,522)
  Net change in note payable to related party                                         (9,197)             (165,930)
  Net change in capital lease obligation                                              (7,785)                    -
  Proceeds from sale of common stock                                                  25,250                64,500
  Proceeds from sale of preferred stock                                               45,000                     -
                                                                                   ---------             ---------

  Net Cash Provided By Financing Activities                                          143,381               145,504
                                                                                  ---------               ---------

Currency translation adjustment                                                       26,534                23,119
                                                                                   ---------             ---------

Net change in cash                                                                  (66,100)             (223,747)
Cash at beginning of period                                                           67,102               256,646
                                                                                   ---------             ---------

Cash at end of period                                                               $  1,002            $   32,899
                                                                                   =========             =========

</TABLE>




<PAGE>


                                 TRUE HEALTH INC
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited interim financial statements of True Health Inc.
(True Health) have been prepared in accordance with accounting principles
generally accepted in the United States of America and the rules of the
Securities and Exchange Commission ("SEC"), and should be read in conjunction
with the audited financial statements and notes thereto contained in True
Health, Inc.'s Annual Financial Statements filed with the SEC on Form 10-KSB and
in respect of the comparative period, the significant acquisition statement
filed with the SEC on Form 8-K. In the opinion of management, all adjustments,
consisting of normal recurring adjustments, necessary for a fair presentation of
financial position and the results of operations for the interim periods
presented have been reflected herein. The results of operations for interim
periods are not necessarily indicative of the results to be expected for the
full year. Notes to the financial statements which would substantially duplicate
the disclosure contained in the audited financial statements for the most recent
fiscal year ended to January 31, 2005, as reported in the Form 10-KSB, have been
omitted.


Note 2 - PREFERRED STOCK

On April 22, 2005, True Health entered into a securities purchase agreement with
four investors to sell preferred shares in four tranches. True Health is to file
a registration statement to register the underlying securities of the agreement.
The preferred stock is convertible into common stock at $0.0625 per share. In
connection with each tranche, True Health will issue 150,000 Series A warrants
to purchase one share of common stock at $0.125 per share and 1,562,5000 Series
B warrants to purchase one share of common stock at $0.04 per share. The Series
A warrants will be exercisable for a period commencing on the date of the
effectiveness of the registration statement and ending four years from the
closing of the respective tranche. The Series B warrants will be exercisable for
a period commencing 90 days after the fourth closing and ending two years after
the effectiveness of the registration statement. The preferred shares receive
cumulative dividends at 2.50% above the prime rate payable quarterly. A summary
of the four tranches is as follows:
<TABLE>
                          Preferred Stock
                 ----------------------------------
    Traunch          Shares           Amount        Closing Date
    -------          ------           ------        ------------
<S>                  <C>              <C>           <C>
       1                3,600         $  45,000     May 2, 2005
       2                4,000            50,000     Five business days after filing registration statement
       3                4,800            60,000     Five business days after effectiveness of registration
                                                    statement
       4                9,600           120,000     30 business days after effectiveness of registration
                                                    statement
                 --------------- ------------------
     Total             22,000         $ 275,000
                 =============== ==================
</TABLE>
Subsequent to the above securities purchase agreement, Management have
renegotiated the terms of this agreement and a revised agreement has been made
effective December 16, 2005. The main terms of this revised agreement are the
same although the Closing dates have been revised to December 19,2005 for the
second closing, January 31, 2006 for the third closing and March 31, for the
fourth closing.


NOTE 3 - SEGMENT INFORMATION

Reportable segments are based on internal organizational structure and are
comprised of Equipment Products and Recruitment Services. The Equipment Products
segment derives revenues from the sale and rental of medical equipment including
its main product range, being pressure relieving systems to public and private
hospitals, nursing homes and individuals. The Recruitment Services segment
derives its revenues from the placement of medical staff, including
radiographers, midwives, and nurses in addition to social care staff

Segment financial information is summarized as follows:

Three months ended October 31, 2005
<TABLE>
                                                                             Corporate
                                          Equipment       Recruitment        and Other             Total
                                             ------          --------        ---------             -----
2005
----
<S>                                       <C>             <C>               <C>               <C>
Revenue                                   $ 653,366        $  513,515        $   7,376        $1,174,257
Net interest expense                              -                 -           11,182            11,182
Depreciation and
  amortization                                    -                 -           31,445            31,445
Net income / (loss)                         241,273             3,560         (204,339)           40,494
Total assets                                757,160           217,872           79,485         1,054,517
Expenditures for
  long-lived assets                          34,900                 -                -            34,900

2004
----
Revenue                                  $  452,451        $  872,489        $   9,447        $1,334,387
Net interest expense                              -                 -           10,435            10,435
Depreciation and
  amortization                                    -                 -           29,525            29,525
Net income (loss)                           195,247             4,320         (333,403)         (133,836)
Total assets                                689,232           351,276          193,990         1,234,498
Expenditures for
  long-lived assets                          23,794                 -                -            23,794


Nine months ended October 31, 2005
                                                                             Corporate
                                          Equipment       Recruitment        and Other             Total
                                             ------          --------        ---------             -----
2005
----
Revenue                                  $1,706,387        $1,578,706       $   26,379        $3,311,472
Net interest expense                              -                 -           36,777            36,777
Depreciation and
  amortization                                    -                 -           83,354            83,354
Net income / (loss)                         699,442             9,480         (763,733)          (54,813)
Total assets                                757,160           217,872           79,485         1,054,517
Expenditures for
  long-lived assets                         114,075                 -                -           114,075

2004
----
Revenue                                  $1,459,228        $3,119,230        $  30,210        $4,608,668
Net interest expense                              -                 -           34,598            34,598
Depreciation and
  amortization                                    -                 -           90,763            90,763
Net income (loss)                           195,247             4,320       (1,244,607)       (1,045,040)
Total assets                                689,232           351,276          193,990         1,234,498
Expenditures for
  long-lived assets                         104,284                 -                -           104,284

</TABLE>


ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Important Information Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Those statements
include indications regarding our intent, belief or current expectations,
including our plans with respect to the sourcing, manufacturing, marketing and
distribution of our products and services, the belief that current levels of
cash and cash equivalents together with cash from operations and existing credit
facilities will be sufficient to meet its working capital requirements for the
next twelve months, our expectations with respect to the performance of the
counterparties to its letter of credit agreements, our plans to invest in
derivative instruments and the collection of accounts receivable, our beliefs
and intent with respect to and the effect of changes in financial accounting
rules on its financial statements. Such statements are subject to a variety of
risks and uncertainties, many of which are beyond the our control, which could
cause actual results to differ materially from those contemplated in such
forward-looking statements, which include, among other things, (i) changes in
the marketplace for our products and services, (ii) the introduction of new
products or pricing changes by our competitors, (iii) changes in exchange rates,
and (iv) changes in the economy. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date hereof. We undertake no obligation to update or revise
the information contained in this Quarterly Report on Form 10-QSB, whether as a
result of new information, future events or circumstances or otherwise.

Critical accounting policies

We have identified the policies below as critical to our business operations and
the understanding of our results of operations. The impact and any associated
risks related to these policies on our business operations is discussed
throughout Management's Discussion and Analysis of Financial Condition and
Results of Operations where such policies affect our reported and expected
financial results. The preparation of this Quarterly Report on Form 10-QSB
requires us to make estimates and assumptions that affect the reported amount of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of our financial statements, and the reported amounts of revenue and
expenses during the reporting period. There can be no assurance that actual
results will not differ from those estimates.

1) Allowance for doubtful accounts

We evaluate the adequacy of the allowance for doubtful accounts at the end of
each quarter. In performing this evaluation, we analyze the payment history of
significant past due accounts, subsequent cash collections on these accounts and
comparative accounts receivable aging statistics. Based on this information,
along with consideration of the general strength of the economy, we develop what
we consider to be a reasonable estimate of the uncollectible amounts included in
accounts receivable. This estimate involves our significant judgment. Actual
uncollectible amounts may differ from our estimate.


2) Provision for obsolete inventory

We estimate our provision for obsolete inventory based on customer orders sold
below cost, to be shipped in the following period and on the amount of similar
unsold inventory at period end. We analyze recent sales and gross margins on
unsold inventory in further estimating the inventory provision. The impact of
the inventory provision is reflected in cost of sales and the related gross
margins in the period that management deems that inventory has become obsolete.
This estimate involves our significant judgment. Actual gross margins on sales
of excess inventory may differ from our estimate.


Three Months Ended October 31, 2005 Compared to Three Months Ended October 31,
 2004

Revenue

Total revenue for the three months ended October 31, 2005 was $1,174,257. This
represents a decrease of $160,130 or 12.0%, when compared to revenue of
$1,334,387 for the three months ended October 31, 2004.

Revenue from the equipment rentals and sales segment increased by $200,915, or
44.4%, to $653,366 in the three months ended October 31, 2005 compared to
$452,451 in the three months ended October 31, 2004. This increase reflects the
continued growth in the equipment division over the past year arising from an
increase in the customer base, specifically through our geographic expansion via
our Distributor Network.

Revenue from recruitment services and placement of medical staff, care and
social workers and nurses was $513,515 for the three months ended October 31,
2005. This represents a reduction of $358,974 or 41.1% compared with revenues of
$872,489 for the three months to October 31, 2004.


Cost of sales

Cost of sales for the three months ended October 31, 2005, compared to the three
months ended October 31, 2004 are shown below:


                                 Three months ended          Three months ended
                                  October 31, 2005             October 31, 2004

Equipment rentals and sales         $196,407  30.1%     $172,790  38.2%

Recruitment services and             454,568  88.5%      708,951  81.3%
 - placement fees

Total                             $  650,975  55.4%    $  881,741  66.1%


The total Gross Profit of $523,281 in the second quarter was $70,635 (15.6%)
higher than the three months ended October 31, 2004 of $452,646.


General and administrative overheads

General and administrative overhead expenditure for the three months ended
October 31, 2005 of $440,160 was $106,362, or 19.5% lower than the amount of
$546,522 incurred in the three months ended October 31, 2004. The main reasons
for these savings are as follows:

o        An improvement in operating efficiency arising from the investment in
         information technology systems and infrastructure in the last quarter
         of the previous financial year. This has enabled a reduction in
         non-sales staff to support the organisation,
o        A reduction in the fixed costs of employing a large sales staff,
         especially recruitment division where revenues and income was
         declining. Higher paid sales managers who had been with the Company for
         a number of years have gradually been replaced with more experienced
         individuals at more competitive remuneration packages. A greater focus
         is being placed on results based commission to staff.


Interest expense

Net Interest expense of $11,182 for the three months ended October 31, 2005, is
compared with $10,435 for the three months ended October 31, 2004. This
represents a marginal increase of $747 and reflects the overall net debt
position of the company during the quarter.


Liquidity and Capital Resources

We have relied primarily on asset-based borrowings, internally generated funds,
stockholder investment and loans, together with trade credit to finance our
operations. Our capital requirements primarily result from working capital
needed to support operations, including increases in inventory and accounts
receivable. Our working capital position has marginally deteriorated from a
deficit of $324,436 as of July 31, 2005 to a deficit of $375,815 as of October
31, 2005. As of October 31, 2005, we had cash and cash equivalents of $1,002
compared to $17,625 as of July 31, 2005.

Operating Cash Flow

Net cash used in operating activities for the three months ended October 31,
2005 showed an improvement $134,837, when comparing the net cash used in
operations for the nine months ended October 31, 2005 of $121,941 which is a
significant improvement on the net cash used of $256,778 for the six months
ended July 31, 2005 and arises out of the beneficial financial effect of the
company's performance on managing its resources, including its inventories,
accounts receivable and payable and due to a significantly improved overall
financial performance for the period.


Credit Facilities

We have a loan agreement with bankers, HSBC, for a term loan that advanced
$237,000 in January 2004 and is due for repayment by November 2007. The loan
attracts a variable rate interest of 2% over UK base rate and there is a
floating charge over the assets of the Company (6.75% at October 31, 2005).

We also have an accounts receivable factoring arrangement with Venture Finance
which is secured by a floating charge over our assets. This facility has
attracts variable rate interest of 1.75% over UK base rate (6.5% at October 31,
2005).

We believe that current levels of cash and cash equivalents ($1,002 at October
31, 2005) together with cash from operations and funds available under our
credit facilities and additional funding exercises, will be sufficient to meet
our capital requirements for the next twelve months.


Nine Months Ended October 31, 2005 Compared to Nine Months Ended October 31,
 2004

Revenue

Total revenue for the nine months ended October 31, 2005 was $3,311,472
representing a decrease of $1,297,196 or 28.1%, when compared to revenue of
$4,608,668 for the nine months ended October 31, 2004. The reduction in revenues
came entirely from a fall in activity in the recruitment division, while the
Company's equipment division generated a modest increase in revenues, as
discussed below.

Revenue from the equipment rentals and sales segment of $1,706,387 increased by
$247,159, or 16.9%, in the nine months ended October 31, 2005, compared to
$1,459,228 for the nine months ended October 31, 2004. This reflects the stable
income stream and growth in the division over the past year, which mainly arose
from an increase in the customer base and through our ongoing geographic
expansion via our Distributor Network.

Revenue from the recruitment services and placement segment decreased by
$1,540,524, to $1,578,706 for the nine months ended October 31, 2005. This
represents a 49.4% decrease on the revenues of $3,119,230 for the nine months to
October 31, 2004. The main reason in the fall in recruitment revenues stemmed
from a shift in clients' purchasing strategies by relying on a fewer number of
core first and second tier suppliers of medical personnel, specifically with
respect to radiography. It also experienced a reduction in the number of sales
staff in this sector. As a result the Company has actively marketed its services
to obtain preferred supplier status with clients in this and other fields,
including social care.


Cost of sales

Cost of sales for the nine months ended October 31, 2005, compared to the nine
months ended October 31, 2004 are as follows:



                                Nine months ended             Nine months ended
                                 October 31, 2005              October 31, 2004

Equipment rentals and sales       $  540,738  31.6%           $  424,458  29.1%

Recruitment services and           1,292,888  81.8%            2,552,026  81.8%
placement fees

Total                             $1,833,626  55.3%      $2,976,484  64.6%


The total Gross Profit for the nine months ended October 31, 2005 was $1,477,845
and represents a reduction of $154,339 (9.5%) compared with the nine months
ended October 31, 2004 of $1,632,184. This decrease in gross margins, compared
with a reduction in total revenues for the same period by 28.1%, and reflects
the reduction in relative terms of the lower margin recruitment business.


General and administrative overheads

General and administrative overhead expenses decreased by $1,146,744, or 43.4%
to $1,495,881 for the nine months to October 31, 2005, compared to overheads of
$2,642,625 for the nine months to October 31, 2004. The main reasons for the
decrease in expenditure are as for the items outlined in the discussion and
analysis for the three months results, earlier in this Report together with the
reduction of $600,000 of consultancy fees, which were not incurred this year.


Interest expense

Net Interest expense of $36,777 for the nine months to October 31, 2005,
increased by $2,179 or 6.3%, compared with $34,598 for the nine months to
October 31, 2004.


Operating Cash Flow

Net cash used in operating activities for the nine months ended October 31, 2005
was $121,941 compared with the net cash used of $288,086 for the nine months
ended October 31, 2004. This mainly arises from the improved trading performance
of the current period. A discussion of the Company's liquidity and credit
facilities is discussed in the section in respect of the results for the three
months.




ITEM 3. CONTROLS AND PROCEDURES

At October 31, 2005, we carried out an evaluation, under the supervision and
with the participation of our management, including our Chief Executive Officer
and Chief Financial Officer, of the effectiveness of the design and operation of
our disclosure controls and procedures pursuant to Rule 13a-14 under the
Securities Exchange Act of 1934, as amended. Based upon that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded that our
disclosure controls and procedures are effective in timely alerting them to
material information relating to us required to be included in our periodic SEC
filings.

There have been no significant changes in our internal controls or in other
factors that could significantly affect our controls subsequent to the date of
that evaluation, and no corrective actions with regard to significant
deficiencies and material weaknesses.









<PAGE>


                           PART II - OTHER INFORMATION



ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits Item Description
     31.1                  Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     31.2                  Certification Pursuant to Section 302 of the
                           Sarbanes-Oxley Act of 2002
     32                    Certification Pursuant to 18 U.S.C. Section 1350, as
                           Adopted Pursuant to Section 906 of the Sarbanes-Oxley
                           Act of 2002

(b) Report on Form 10-KSB

On May 17, 2005, we filed a report on Form 10-KSB relating to our results for
the year ended January 31, 2005.


(c) Report on Form 10-QSB

On June 14, 2005, we filed a report on Form 10-QSB relating to our results for
the quarter ended April 30, 2005.


(d) Report on Form 8K

On December 6, 2005 we files a report of Form 8K relating to the sale of fifty
percent of the recruitment business.







                                                     SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

         Dated:  December 20, 2005.

                                               TRUE HEALTH, INC.

                                               BY: David Francis
                                                  -------------------
                                                  David Francis, CEO



                                               BY: Ian Wylie
                                                   ------------------
                                                   Ian Wylie, CFO





<PAGE>



                                  Exhibit 31.1

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, David Francis, certify that:

1.       I have reviewed the quarterly report on Form 10-QSB of True Health,
         Inc. for the period ended October 31, 2005 (this
         "Report");


2.          Based on my knowledge, this Report does not contain any untrue
            statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this Report;


3.          Based on my knowledge, the financial statements, and other financial
            information included in this Report, fairly present in all material
            respects the financial condition, results of operations and cash
            flows of the registrant as of, and for, the periods presented in
            this Report;


4.          The registrant's other certifying officers and I are responsible for
            establishing and maintaining disclosure controls and procedures (as
            defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant
            and we have:

(a)         designed such disclosure controls and procedures to ensure that
            material information relating to the registrant, including its
            consolidated subsidiaries, is made known to us by others within
            those entities, particularly during the period in which this Report
            is being prepared;

(b)      evaluated the  effectiveness of the registrant's  disclosure  controls
         and procedures as of a date within 90 days prior to the
            filing date of this Report (the "Evaluation Date"); and


(c)         presented in this Report our conclusions about the effectiveness of
            the disclosure controls and procedures based on our evaluation as of
            the Evaluation Date;


     5. The registrant's other certifying officers and I have disclosed, based
     on our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors:
(a)           all significant deficiencies in the design or operation of
              internal controls which could adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
(b)           any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and


     6. The registrant's other certifying officers and I have indicated in this
     Report whether or not there were significant changes in internal controls
     or in other factors that could significantly affect internal controls
     subsequent to the date of our most recent evaluation, including any
     corrective actions with regard to significant deficiencies and material
     weaknesses.

Dated: December 20, 2005


David Francis
--------------------------------------
David Francis, CEO


                                  Exhibit 31.2

                            Certification Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

I, Ian Wylie, certify that:

7.     I have reviewed the quarterly report on Form 10-QSB of True Health, Inc.
       for the period ended October 31, 2005 (this "Report");

8.     Based on my knowledge, this Report does not contain any untrue statement
       of a material fact or omit to state a material fact necessary to make the
       statements made, in light of the circumstances under which such
       statements were made, not misleading with respect to the period covered
       by this Report;

9.     Based on my knowledge, the financial statements, and other financial
       information included in this Report, fairly present in all material
       respects the financial condition, results of operations and cash flows of
       the registrant as of, and for, the periods presented in this Report;

10.    The registrant's other certifying officers and I are responsible for
       establishing and maintaining disclosure controls and procedures (as
       defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
       we have:

       (d)    designed such disclosure controls and procedures to ensure that
              material information relating to the registrant, including its
              consolidated subsidiaries, is made known to us by others within
              those entities, particularly during the period in which this
              Report is being prepared;
       (e)    evaluated the effectiveness of the registrant's disclosure
              controls and procedures as of a date within 90 days prior to the
              filing date of this Report (the "Evaluation Date"); and
       (f)    presented in this Report our conclusions about the effectiveness
              of the disclosure controls and procedures based on our evaluation
              as of the Evaluation Date;

11.    The registrant's other certifying officers and I have disclosed, based on
       our most recent evaluation, to the registrant's auditors and the audit
       committee of registrant's board of directors: (c) all significant
       deficiencies in the design or operation of internal controls which could
       adversely affect the registrant's
              ability to record, process, summarize and report financial data
              and have identified for the registrant's auditors any material
              weaknesses in internal controls; and
       (d)    any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal controls; and

12.    The registrant's other certifying officers and I have indicated in this
       Report whether or not there were significant changes in internal controls
       or in other factors that could significantly affect internal controls
       subsequent to the date of our most recent evaluation, including any
       corrective actions with regard to significant deficiencies and material
       weaknesses.


Dated: December 20, 2005


Ian Wylie
--------------------------------------
Ian Wylie, CFO



                                   Exhibit 32

         Certification Pursuant to 18U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

Each   of the undersigned hereby certifies, for the purposes of section 1350 of
       chapter 63 of title 18 of the United States Code, in his capacity as an
       officer of True Health, Inc. ("True Health"), that, to his knowledge, the
       quarterly report on Form 10-QSB of True Health, Inc. for the period ended
       October 31, 2005, fully complies with the requirements of Section 13(a)
       of the Securities Exchange Act of 1934 and that the information contained
       in such amendment to said report fairly presents, in all material
       respects, the financial condition and results of operation of True
       Health.

Dated: December 20, 2005




David Francis
--------------------------------------
David Francis, CEO




Ian Wylie
--------------------------------------
Ian Wylie, CFO